Read related content in the entries on therapy classification of the research pathways.
The exceptional possibility for individual patients with life-threatening, long-lasting or seriously debilitating illness to access unauthorized medicines outside a clinical trial, where no satisfactory authorized treatment is available.
Read related content in the entries on therapy classification of the research pathways.